Literature DB >> 7240412

Abnormalities in membrane phospholipid organization in sickled erythrocytes.

B Lubin, D Chiu, J Bastacky, B Roelofsen, L L Van Deenen.   

Abstract

In contrast to the wealth of information concerning membrane phospholipid asymmetry in normal human erythrocytes, very little is known about membrane phospholipid organization in pathologic erythrocytes. Since the spectrin-actin lattice, which has been suggested to play an important role in stabilizing membrane phospholipid asymmetry, is abnormal in sickled erythrocytes, we determined the effects of sickling on membrane phospholipid organization. We used two enzymatic probes: been venom phospholipase A2 and Staphylococcus aureus sphingomyelinase C, which do not penetrate the membrane and react only with phospholipids located in the outer leaflet of the bilayer. Our results suggest that the distribution of glycerophospholipids within the membrane of sickled cells is different from that in nonsickled cells. Compared with the normal erythrocyte, the outer membrane leaflet of the deoxygenated, reversibly sickled cells (RSC) and irreversibly sickled cells (ISC) was enriched in phosphatidyl ethanolamine in addition to containing phosphatidyl serine. These changes were compensated for by a decrease in phosphatidyl choline in that layer. The distribution of sphingomyelin over the two halves of the bilayer was unaffected by sickling. In contrast to ICS, where the organization of phospholipids was abnormal under both oxy and deoxy conditions, reoxygenation of RSC almost completely restored the organization of membrane phospholipids to normal. These results indicate that the process of sickling induces an abnormality in the organization of membrane phospholipids to normal. These results indicate that the process of sickling induces an abnormality in the organization of membrane lipids in RSC which become permanent in ISC.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240412      PMCID: PMC370739          DOI: 10.1172/jci110200

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Organization of phospholipids in human red cell membranes as detected by the action of various purified phospholipases.

Authors:  R F Zwaal; B Roelofsen; P Comfurius; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1975-09-16

2.  The removal of leukocytes and platelets from whole blood.

Authors:  E Beutler; C West; K G Blume
Journal:  J Lab Clin Med       Date:  1976-08

3.  Phospholipase A2 as a probe of phospholipid distribution in erythrocyte membranes. Factors influencing the apparent specificity of the reaction.

Authors:  J K Martin; M G Luthra; M A Wells; R P Watts; D J Hanahan
Journal:  Biochemistry       Date:  1975-12-16       Impact factor: 3.162

4.  Elevated erythrocyte calcium in sickle cell disease.

Authors:  J W Eaton; T D Skelton; H S Swofford; C E Kolpin; H S Jacob
Journal:  Nature       Date:  1973-11-09       Impact factor: 49.962

5.  Lytic and non-lytic degradation of phospholipids in mammalian erythrocytes by pure phospholipases.

Authors:  C M Colley; R F Zwaal; B Roelofsen; L L van Deenen
Journal:  Biochim Biophys Acta       Date:  1973-04-25

6.  Differences in the reactivity of phospholipids with FDNB in normal RBC, sickle cells and RBC ghosts.

Authors:  S E Gordesky; G V Marinetti; G B Segel
Journal:  Biochem Biophys Res Commun       Date:  1972-06-09       Impact factor: 3.575

7.  Interaction of the erythrocyte--membrane protein, spectrin, with model membrane systems.

Authors:  C Sweet; J E Zull
Journal:  Biochem Biophys Res Commun       Date:  1970-10-09       Impact factor: 3.575

8.  The reaction of chemical probes with the erythrocyte membrane.

Authors:  S E Gordesky; G V Marinetti; R Love
Journal:  J Membr Biol       Date:  1975       Impact factor: 1.843

9.  Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells.

Authors:  S E Lux; K M John; M J Karnovsky
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

10.  Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity.

Authors:  R P Hebbel; M A Boogaerts; J W Eaton; M H Steinberg
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

View more
  47 in total

1.  Antiphospholipid antibodies in homozygous sickle cell disease.

Authors:  K De Ceulaer; M A Khamashta; E N Harris; G R Serjeant; G R Hughes
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

2.  Molecular defect in the sickle erythrocyte skeleton. Abnormal spectrin binding to sickle inside-our vesicles.

Authors:  O S Platt; J F Falcone; S E Lux
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

Review 3.  Sickle cell states and the anaesthetist.

Authors:  D W Esseltine; M R Baxter; J C Bevan
Journal:  Can J Anaesth       Date:  1988-07       Impact factor: 5.063

Review 4.  Transmembrane movements of lipids.

Authors:  A Zachowski; P F Devaux
Journal:  Experientia       Date:  1990-06-15

5.  Human erythrocyte protein 4.1 is a phosphatidylserine binding protein.

Authors:  A C Rybicki; R Heath; B Lubin; R S Schwartz
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

6.  Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics, and spectrin-hemoglobin cross-linking.

Authors:  L M Snyder; N L Fortier; J Trainor; J Jacobs; L Leb; B Lubin; D Chiu; S Shohet; N Mohandas
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

7.  In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats.

Authors:  S K Jain
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Rhnull human erythrocytes have an abnormal membrane phospholipid organization.

Authors:  F Kuypers; M van Linde-Sibenius-Trip; B Roelofsen; M J Tanner; D J Anstee; J A Op den Kamp
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

9.  Erythrocyte membrane glycerophospholipid organization is normal in multiple sclerosis.

Authors:  M I Hunter; M S Lao; D L Davidson
Journal:  Neurochem Res       Date:  1984-01       Impact factor: 3.996

10.  Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.

Authors:  R H Wang; G Phillips; M E Medof; C Mold
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.